Happy Saturday and welcome back to Endpoints Weekly! We had a flurry of news this week, so let’s dive in.
Our team has the latest news and analysis around the Trump administration’s executive order intended ...
↧
What we know about ‘most favored nation’; GSK’s $1.2B MASH deal; Bayer details staff cuts; and more
↧